Research Output per year
Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
- 27 Similar Profiles
Stomach Neoplasms
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Breast Neoplasms
Medicine & Life Sciences
Drug Therapy
Medicine & Life Sciences
Survival
Medicine & Life Sciences
oxaliplatin
Medicine & Life Sciences
Stomach
Medicine & Life Sciences
docetaxel
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1986 2019
A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer
Bang, Y. J., Kang, Y. K., Ng, M., Chung, H., Wainberg, Z. A., Gendreau, S., Chan, W. Y., Xu, N., Maslyar, D., Meng, R., Chau, I. & Ajani, J. A., 2019 Feb 1, In : European Journal of Cancer. 108, p. 17-24 8 p.Research output: Contribution to journal › Article
Esophagogastric Junction
Stomach
Disease-Free Survival
Placebos
Neoplasms
Avelumab (anti-PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: Phase 1b results from the JAVELIN Solid Tumor trial
Chung, H., Arkenau, H. T., Lee, J., Rha, S., Oh, D. Y., Wyrwicz, L., Kang, Y. K., Lee, K. W., Infante, J. R., Lee, S. S., Kemeny, M., Keilholz, U., Melichar, B., Mita, A., Plummer, R., Smith, D., Gelb, A. B., Xiong, H., Hong, J., Chand, V. & 1 others, 2019 Feb 4, In : Journal for ImmunoTherapy of Cancer. 7, 1, 30.Research output: Contribution to journal › Article
Esophagogastric Junction
Stomach
Maintenance
Disease-Free Survival
Neoplasms
1
Citation
(Scopus)
Differences in the efficacies of pazopanib and gemcitabine/docetaxel as second-line treatments for metastatic soft tissue sarcoma
Kim, J. H., Park, H. S., Heo, S. J., Kim, S. K., Han, J. W., Shin, K. H., Kim, S. H., Hur, H., Kim, K. S., Choi, Y., Kim, S., Lee, Y. H., Suh, J., Ahn, J. B., Chung, H., Noh, S. H., Rha, S. & Kim, H. S., 2019 Feb 1, In : Oncology (Switzerland). 96, 2, p. 59-69 11 p.Research output: Contribution to journal › Article
docetaxel
gemcitabine
Sarcoma
Therapeutics
Synovial Sarcoma
Maintenance avelumab versus continuation of first-line chemotherapy in gastric cancer: JAVELIN Gastric 100 study design
Moehler, M., Ryu, M. H., Dvorkin, M., Lee, K. W., Coşkun, H., Wong, R., Chung, H., Poltoratsky, A., Tsuji, A., Yen, C. J., Muntean, A. S., Le Sourd, S., Vaccaro, G. M., Overton, L., Boku, N., Wainberg, Z. A., Patel, M., Sharma, M., Xiong, H., Conti, I. & 2 others, 2019 Feb 1, In : Future Oncology. 15, 6, p. 567-577 11 p.Research output: Contribution to journal › Article
Stomach Neoplasms
Esophagogastric Junction
Stomach
oxaliplatin
Maintenance
Randomised phase II trial comparing four front-line doublets in Asian patients with metastatic gastric cancer
Kim, C., Chon, H. J., Kim, J. H., Jung, M., Nam, C. M., Kim, H. S., Kang, B., Chung, H. & Rha, S., 2019 May 1, In : European Journal of Cancer. 112, p. 20-28 9 p.Research output: Contribution to journal › Article
docetaxel
Fluorouracil
Stomach Neoplasms
Paclitaxel
Disease-Free Survival